[
  {
    "ts": "2026-01-29T03:18:14+00:00",
    "headline": "Gilead’s Trodelvy Win In TNBC Highlights Evolving Oncology Growth Story",
    "summary": "Gilead Sciences reported positive Phase 3 results for Trodelvy in combination with Keytruda in first-line PD-L1+ metastatic triple-negative breast cancer. The data were published in The New England Journal of Medicine, with new regulatory submissions underway to the FDA and EMA. The update centers on Trodelvy's role in Gilead's oncology pipeline and the potential for expanded use in breast cancer treatment. Gilead Sciences, listed as NasdaqGS:GILD, is drawing attention as it advances its...",
    "url": "https://finance.yahoo.com/news/gilead-trodelvy-win-tnbc-highlights-031814187.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ab97992d-88a7-3016-81ac-91f9b3b04d5d",
      "content": {
        "id": "ab97992d-88a7-3016-81ac-91f9b3b04d5d",
        "contentType": "STORY",
        "title": "Gilead’s Trodelvy Win In TNBC Highlights Evolving Oncology Growth Story",
        "description": "",
        "summary": "Gilead Sciences reported positive Phase 3 results for Trodelvy in combination with Keytruda in first-line PD-L1+ metastatic triple-negative breast cancer. The data were published in The New England Journal of Medicine, with new regulatory submissions underway to the FDA and EMA. The update centers on Trodelvy's role in Gilead's oncology pipeline and the potential for expanded use in breast cancer treatment. Gilead Sciences, listed as NasdaqGS:GILD, is drawing attention as it advances its...",
        "pubDate": "2026-01-29T03:18:14Z",
        "displayTime": "2026-01-29T03:18:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HAEiJmFsYXJTRBPxnneP6w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hXB9F2qU7k4qk3_k1DQd9A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-trodelvy-win-tnbc-highlights-031814187.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-trodelvy-win-tnbc-highlights-031814187.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]